DNA copy number alterations (CNAs) are genetic changes that can produce adverse effects
in numerous human diseases, including cancer. CNAs are segments of DNA that have been …

Genomic DNA copy-number alterations (CNAs) are associated with complex diseases,
including cancer: CNAs are indeed related to tumoral grade, metastasis, and patient …

Motivation: Recurrent DNA copy number alterations (CNA) measured with array comparative
genomic hybridization (aCGH) reveal important molecular features of human genetics and …

Motivation: Array comparative genomic hybridization (aCGH) is a pervasive technique used
to identify chromosomal aberrations in human diseases, including cancer. Aberrations are …

Array comparative genomic hybridization (CGH) is a high resolution technique to assess
DNA copy number variation. Identifying breakpoints where copy number changes will …

Cancer development and progression typically features genomic instability frequently
resulting in genomic changes involving DNA copy number gains or losses. Identifying the …

Array comparative genomic hybridization (aCGH) provides a high-resolution and high-
throughput technique for screening of copy number variations (CNVs) within the entire …

Background Microarray-CGH experiments are used to detect and map chromosomal
imbalances, by hybridizing targets of genomic DNA from a test and a reference sample to …

Array comparative genomic hybridization (aCGH) allows identification of copy number
alterations across genomes. The key computational challenge in analyzing copy number …

The recently developed array-based comparative genomic hybridization (array CGH)
technique measures DNA copy number aberrations that occur as causes or consequences …